Massive Bio shared a post on LinkedIn:
“Our Co-Founder and CEO Selin Kurnaz, PhD has been recognized among the honorees in the Business and Entrepreneurship category at the TOA Awards 2026!
This recognition celebrates the vision and leadership driving Massive Bio’s mission: connecting cancer patients worldwide with life saving clinical trials through AI driven precision oncology.
We are proud to see this achievement honored alongside such an impressive group of business leaders and entrepreneurs.”
You can also read: Selin Kurnaz Recognized Among The 100 Most Influential CEOs in Oncology in 2025
